Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-27

FDA Approved: DIFICID — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved DIFICID (fidaxomicin) from Merck as the original application for the treatment of Clostridioides difficile infection. This marks the approval o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dificid (fidaxomicin)

Snippet

ORIG AP for DIFICID (FIDAXOMICIN)